Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether continuous clopidogrel dose adjustment
targeted after platelet function testing improves outcomes during 12 months of follow-up in
acute coronary syndrome patients treated with coronary artery stenting and with determined
high platelet reactivity on clopidogrel.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zagreb
Collaborators:
Clinical Hospital Centre Zagreb Ministry of Science, Education and Sport, Republic of Croatia